291 related articles for article (PubMed ID: 33020707)
1. Structural insight into the recognition of
Mahalapbutr P; Kongtaworn N; Rungrotmongkol T
Comput Struct Biotechnol J; 2020; 18():2757-2765. PubMed ID: 33020707
[TBL] [Abstract][Full Text] [Related]
2. Binding of the Methyl Donor
Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
[TBL] [Abstract][Full Text] [Related]
3. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
Deng J; Gong F; Li Y; Tan X; Liu X; Yang S; Chen X; Wang H; Liu Q; Shen C; Zhou L; Chen Y
Virol Sin; 2024 Jul; ():. PubMed ID: 38969340
[TBL] [Abstract][Full Text] [Related]
6. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
Shi L; Wen Z; Song Y; Wang J; Yu D
J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
[TBL] [Abstract][Full Text] [Related]
7. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA; Menendez JA
Viruses; 2020 May; 12(5):. PubMed ID: 32397643
[TBL] [Abstract][Full Text] [Related]
8. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2.
Balieiro AM; Anunciação ELS; Costa CHS; Qayed WS; Silva JRA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430451
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
Azad GK
Biochem Biophys Rep; 2020 Dec; 24():100833. PubMed ID: 33072893
[TBL] [Abstract][Full Text] [Related]
10. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2.
Thomas J; Kumar S; Satija J
J Biomol Struct Dyn; 2024; 42(4):1999-2012. PubMed ID: 37129206
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
12. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
[TBL] [Abstract][Full Text] [Related]
13. High-resolution structures of the SARS-CoV-2 2'-
Rosas-Lemus M; Minasov G; Shuvalova L; Inniss NL; Kiryukhina O; Brunzelle J; Satchell KJF
Sci Signal; 2020 Sep; 13(651):. PubMed ID: 32994211
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
15. In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex.
Liang J; Pitsillou E; Burbury L; Hung A; Karagiannis TC
Chem Phys Lett; 2021 Jul; 774():138618. PubMed ID: 33850334
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
El Hassab MA; Ibrahim TM; Al-Rashood ST; Alharbi A; Eskandrani RO; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):727-736. PubMed ID: 33685335
[TBL] [Abstract][Full Text] [Related]
17. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
[TBL] [Abstract][Full Text] [Related]
18. Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.
Dutta M; Iype E
Biochem Biophys Rep; 2021 Sep; 27():101069. PubMed ID: 34250275
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
Wang Y; Sun Y; Wu A; Xu S; Pan R; Zeng C; Jin X; Ge X; Shi Z; Ahola T; Chen Y; Guo D
J Virol; 2015 Aug; 89(16):8416-27. PubMed ID: 26041293
[TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
